Publication at Faculty of Medicine in Hradec Králové |
2019
Abstract
The aim of this article is to give the review about the treatment of urticaria. This article gives especially the review about the therapy with antihistamins, about their pharmacology and gives the information about the new antihistaminic drug bilastin.
The proven efficacy and safety profile of bilastine, its low potential for CNS impairment confirm that this compound has a forerunning place in therapy among second-generation H1 antihistamines in the management of urticaria.